Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,871 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prolonged neurologic symptoms following immune effector cell-associated neurotoxicity syndrome in patients with large B cell lymphoma treated with chimeric antigen receptor-modified T cell therapy.
Maillie L, Nasta SD, Svoboda J, Barta SK, Chong EA, Garfall AL, Gill SI, Porter DL, Schuster SJ, Catania C, Frey NV, Landsburg DJ. Maillie L, et al. Among authors: porter dl. Transplant Cell Ther. 2025 Jan 21:S2666-6367(25)00912-1. doi: 10.1016/j.jtct.2025.01.884. Online ahead of print. Transplant Cell Ther. 2025. PMID: 39848443
Long-term safety of lentiviral or gammaretroviral gene-modified T cell therapies.
Jadlowsky JK, Hexner EO, Marshall A, Grupp SA, Frey NV, Riley JL, Veloso E, McConville H, Rogal W, Czuczman C, Hwang WT, Li Y, Leskowitz RM, Farrelly O, Karar J, Christensen S, Barber-Rotenberg J, Gaymon A, Aronson N, Bernstein W, Melenhorst JJ, Roche AM, Everett JK, Zolnoski SA, McFarland AG, Reddy S, Petrichenko A, Cook EJ, Lee C, Gonzalez VE, Alexander K, Kulikovskaya I, Ramírez-Fernández Á, Minehart JC, Ruella M, Gill SI, Schuster SJ, Cohen AD, Garfall AL, Shah PD, Porter DL, Maude SL, Levine BL, Siegel DL, Chew A, McKenna S, Lledo L, Davis MM, Plesa G, Herbst F, Stadtmauer EA, Tebas P, DiNofia A, Haas A, Haas NB, Myers R, O'Rourke DM, Svoboda J, Tanyi JL, Aplenc R, Jacobson JM, Ko AH, Cohen RB, June CH, Bushman FD, Fraietta JA. Jadlowsky JK, et al. Among authors: porter dl. Nat Med. 2025 Jan 20. doi: 10.1038/s41591-024-03478-6. Online ahead of print. Nat Med. 2025. PMID: 39833408
A Randomized, Blinded, Vehicle-Controlled Dose-Ranging Study to Evaluate and Characterize Remdesivir Efficacy Against Ebola Virus in Rhesus Macaques.
Zumbrun EE, Garvey CB, Wells JB, Lynn GC, Van Tongeren SA, Steffens JT, Wetzel KS, Wetzel DL, Esham HL, Garza NL, Lee ED, Scruggs JL, Rossi FD, Brown ES, Weidner JM, Gomba LM, O'Brien KA, Jay AN, Zeng X, Akers KS, Kallgren PA, Englund E, Meinig JM, Kugelman JR, Moore JL, Bloomfield HA, Norris SL, Bryan T, Scheuerell CH, Walters J, Mollova N, Blair C, Babusis D, Cihlar T, Porter DP, Singh B, Hedskog C, Bavari S, Warren TK, Bannister R. Zumbrun EE, et al. Among authors: porter dp. Viruses. 2024 Dec 18;16(12):1934. doi: 10.3390/v16121934. Viruses. 2024. PMID: 39772240 Free PMC article.
DDX50 cooperates with STAU1 to effect stabilization of pro-differentiation RNAs.
Miao W, Porter DF, Siprashvili Z, Ferguson ID, Ducoli L, Nguyen DT, Ko LA, Lopez-Pajares V, Srinivasan S, Hong AW, Yang YY, Cao Z, Meyers RM, Meyers JM, Tao S, Wang Y, Khavari PA. Miao W, et al. Among authors: porter df. Cell Rep. 2025 Jan 6;44(1):115174. doi: 10.1016/j.celrep.2024.115174. Online ahead of print. Cell Rep. 2025. PMID: 39764852 Free article.
Tumor Lysis Syndrome in Acute Myeloid Leukemia Patients Treated With a Venetoclax Based Regimen.
Rowe M, Babushok D, Carroll M, Carulli A, Frey N, Gill S, Hexner E, Hirsh R, Hossain N, Lai C, Loren A, Luger S, Maillard I, McCurdy S, Matthews A, Martin ME, Paralkar VR, Perl A, Porter D, Pratz K, Stadtmauer E, Bruno XJ. Rowe M, et al. Among authors: porter d. Eur J Haematol. 2024 Dec 26. doi: 10.1111/ejh.14371. Online ahead of print. Eur J Haematol. 2024. PMID: 39726154
SARS-CoV-2 resistance analyses from the Phase 3 PINETREE study of remdesivir treatment in nonhospitalized participants.
Rodriguez L, Lee HW, Li J, Martin R, Han D, Xu S, Moshiri J, Peinovich N, Camus G, Perry JK, Hyland RH, Porter DP, Abdelghany M, Götte M, Hedskog C. Rodriguez L, et al. Among authors: porter dp. Antimicrob Agents Chemother. 2024 Dec 19:e0123824. doi: 10.1128/aac.01238-24. Online ahead of print. Antimicrob Agents Chemother. 2024. PMID: 39699245 Free article.
Lisocabtagene Maraleucel for Relapsed/Refractory Large B-Cell Lymphoma: A Cell Therapy Consortium Real-World Analysis.
Riedell PA, Grady CB, Nastoupil LJ, Luna De Abia A, Ahmed N, Maziarz RT, Hu M, Brower J, Hwang WT, Schuster SJ, Chen AI, Oluwole OO, Bachanova V, McGuirk JP, Perales MA, Bishop MR, Porter DL. Riedell PA, et al. Among authors: porter dl. Blood Adv. 2024 Dec 10:bloodadvances.2024014164. doi: 10.1182/bloodadvances.2024014164. Online ahead of print. Blood Adv. 2024. PMID: 39657136
Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation.
Winge MCG, Nasrallah M, Jackrazi LV, Guo KQ, Fuhriman JM, Szafran R, Ramanathan M, Gurevich I, Nguyen NT, Siprashvili Z, Inayathullah M, Rajadas J, Porter DF, Khavari PA, Butte AJ, Marinkovich MP. Winge MCG, et al. Among authors: porter df. Sci Transl Med. 2024 Dec 11;16(777):eade5915. doi: 10.1126/scitranslmed.ade5915. Epub 2024 Dec 11. Sci Transl Med. 2024. PMID: 39661704
Disease-Linked Regulatory DNA Variants and Homeostatic Transcription Factors in Epidermis.
Porter DF, Meyers RM, Miao W, Reynolds DL, Hong AW, Yang X, Mondal S, Siprashvili Z, Srinivasan S, Ducoli L, Meyers JM, Nguyen DT, Ko LA, Kellman L, Elfaki I, Guo M, Winge MC, Lopez-Pajares V, Porter IE, Tao S, Khavari PA. Porter DF, et al. bioRxiv [Preprint]. 2024 Nov 11:2024.11.07.622542. doi: 10.1101/2024.11.07.622542. bioRxiv. 2024. PMID: 39605549 Free PMC article. Preprint.
1,871 results